Identification of The Immune Subtype Among Muscle-invasive Bladder Cancer Patients by Multiple Datasets

Identification of The Immune Subtype Among Muscle-invasive Bladder Cancer Patients by Multiple Datasets

Background: Immunotherapies including PD-1/PD-L1 antibodies have been approved for the treatment of Muscle-invasive Bladder Cancer (MIBC) patients. However, immunotherapies could only be beneficial for about 20% MIBC patients. Thus, identification of the immune subtype is becoming increasingly impor...

Full description

Saved in:
Bibliographic Details
Main Authors: Khyber Shinwari, Zihao Chen, Guojun Liu, Lu Chen, Mikhail A. Bolkov, Irina A. Tuzankina, Valery A. Chereshnev
Format: Article
Language:English
Published: Interna Publishing 2022-04-01
Series:Acta Medica Indonesiana
Subjects:
Molecular subtype
Immunotherapy
MIBC
Immunotype
TMB
Bioinformatics
Online Access:http://www.actamedindones.org/index.php/ijim/article/view/1955
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.actamedindones.org/index.php/ijim/article/view/1955

Similar Items